Collegium Pharmaceutical Inc., of Canton, Mass., appointed Douglas Carlson vice president of business development...EntreMed Inc., of Rockville, Md., appointed Ken K. Ren CEO, and added James Huang and Y. Alexander Wu to its board

Juventas Therapeutics Inc., of Cleveland, named Paul Resnick vice president of business development

NewLink Genetics Corp., of Ames, Iowa, appointed Brian Wiley vice president of business development

Anne-Marie Swift will serve as vice president and European marketing director...Ohr Pharmaceuticals Inc., of New York, added Jeffrey S. Heier and Daniel Roth to its scientific advisory board...Tris Pharma, of Monmouth Junction, N.J., appointed Jonathan Berlent vice president of business development

DCPrime BV, of Amsterdam, the Netherlands, named Marcel Zwaal CEO and Anthony Hall chief medical officer...Theratechnologies Inc., of Montreal, appointed Luc Tanguay interim president and CEO...Zyngenia Inc., of Gaithersburg, Md., added Christian Itin and Jason Rhodes to its board

Imprimis Pharmaceuticals Inc., of Solana Beach, Calif., added Lee S. Simon and Allan Green to its science and regulatory advisory board...Islet Sciences Inc., of New York, added Kevan Herold and Morton Printz to its scientific advisory board

Eli Lilly and Co., of Indianapolis, named Michael Harrington senior vice president and general counsel...VacInnate Corp., of Cranbury, N.J., appointed Christine Mayer vice president of business development and Katalin Abraham vice president of regulatory affairs

he will chair the audit committee and serve on the compensation committee...Elcelyx Therapeutics Inc., of San Diego, named Mark Wiggins senior vice president of business development and added Ginger Graham to its board

Agios Pharmaceuticals Inc., of Cambridge, Mass., named Robert DeVita vice president of chemistry, Marion Dorsch vice president of biology and John Evans vice president of business development and operations

Acella Pharmaceuticals Inc., of Atlanta, appointed Allen Fields vice president and head of R&D...Rusty" Williams president and CEO and named Brian Atwood chairman

Acella Pharmaceuticals Inc., of Atlanta, appointed Allen Fields vice president and head of R&D...Adeona Pharmaceuticals Inc., of Ann Arbor, Mich., appointed Jeff Riley president and CEO, added C. Evan Ballantyne as chief financial officer and named Scott L. Tarriff and Nelson K. Stacks to the board...AMAG Pharmaceuticals Inc., of Lexington, Mass., appointed Rajiv De Silva and Gino Santini to its board

MethylGene Inc., of Montreal, appointed Joseph Walewicz vice president of business and corporate development

Creabilis SA, of Luxembourg, named Alex Leech vice president and head of finance of operations, appointed James Sandy senior vice president and head of development and added Peter Spargo as senior vice president for chemistry, manufacturing and controls

Evan Dick as senior vice president of business development...and Lisa Wittmer as vice president of regulatory affairs

PolyTherics Ltd., of London, named John Burt CEO and board member after Keith Powell stepped down...Resolve Therapeutics LLC, of Seattle, named Peter Kiener chairman and added Somu Subramaniam as an observer to the board...Selecta Biosciences Inc., of Watertown, Mass., appointed Peter Keller vice president of business development and alliance management

It also named Patrick Hwu and Mario Sznol to its recently formed scientific and medical advisory board and named Martin Schroeder to its board

Numerate Inc., of San Bruno, Calif., appointed David Jobes senior vice president of business and corporate development...Proteostasis Therapeutics Inc., of Cambridge, Mass., named Alfred Goldberg and Daniel Finley scientific co-founders...It also appointed Suzanne L. Bruhn, Vijay B. Samant and Timothy P. Walbert to its board

Addex Pharmaceuticals Ltd., of Geneva, added Hoyoung Huh and Oleg Nodelman to its board...Columbia Laboratories Inc., of Livingston, N.J., appointed Kip Martin vice president of business development

Infinity Pharmaceuticals Inc., of Cambridge, Mass., appointed Joshua D. Hamermesh vice president of business and corporate development